APP and Alzheimer disease: The hydrolysis of N-linked glycosylated amyloid β precursor protein (APP) to amyloid β peptide is a marker of AD, and O-linked glycosylation interferes with the proteolysis of APP and affects the pathological changes related to AD (Singh et al., 2022).